Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Passage Bio ( (PASG) ) has issued an announcement.
On March 4, 2026, Passage Bio, Inc. entered into a lease termination agreement with Hopewell Campus Owner LLC, ending a 15-year laboratory lease originally commenced in March 2021 for approximately 62,000 square feet of space. The company agreed to pay about $4.8 million in termination fees plus accrued rent through February 14, 2026, following its January 2025 restructuring, after which it had already ceased all operations at the Hopewell facility.
After executing the termination agreement, Passage Bio reported that its cash and cash equivalents are expected to fund operations through the first quarter of 2027. This updated runway estimate reflects the reduced facility obligations but remains subject to uncertainty, as changes in the operating plan or unforeseen factors could cause the company to exhaust capital sooner than anticipated.
The most recent analyst rating on (PASG) stock is a Buy with a $21.00 price target. To see the full list of analyst forecasts on Passage Bio stock, see the PASG Stock Forecast page.
Spark’s Take on PASG Stock
According to Spark, TipRanks’ AI Analyst, PASG is a Neutral.
The score is held down primarily by weak financial fundamentals (no revenue, ongoing losses, and a sharply deteriorated equity position vs. debt) and bearish technical signals (price below key moving averages with negative MACD). Positive corporate milestones and an extended stated cash runway provide some support, but valuation is not attractive on earnings metrics given continued losses.
To see Spark’s full report on PASG stock, click here.
More about Passage Bio
Passage Bio, Inc. is a biotechnology company that leases and operates specialized laboratory space to support its research and development activities. The company’s facilities, such as the previously leased 62,000 square feet of laboratory space in Hopewell, are core to its operational footprint and cost structure in the life sciences sector.
Average Trading Volume: 58,868
Technical Sentiment Signal: Strong Sell
Current Market Cap: $28.2M
Find detailed analytics on PASG stock on TipRanks’ Stock Analysis page.